-
1.
公开(公告)号:WO2022240786A1
公开(公告)日:2022-11-17
申请号:PCT/US2022/028429
申请日:2022-05-10
Applicant: ABBVIE INC.
Inventor: HAYSLIP, John , KYE, Steve, H. , AINSWORTH, William, B.
IPC: A61K31/167 , A61K31/18 , A61K31/337 , A61K31/635 , A61K31/706 , A61P35/00
Abstract: The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine for treating myelodysplastic syndromes (MDS).